Minocycline for brain health in sickle cell disease
Treatments studied
Part of Blood & lymphatic, Brain & nervous system, Genetic & congenital, Mental health clinical trials.
This study tests whether the antibiotic minocycline, which may also reduce inflammation in the brain, can help protect thinking and memory in adults with sickle cell disease. It is an early-stage trial to see if the drug is safe and whether it might improve daily mental function.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have sickle cell disease with the HbSS or HbS-β0thalassemia types (your doctor can confirm)
- You do not have a history of stroke or other brain conditions
- You are not on monthly blood transfusions
- You are not pregnant or breastfeeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing a digital program to help improve working memory (the ability to hold and use information in your mind) for children with sickle cell disease. If you join, you'll use a computer-based training program at home and researchers will see if it works and is easy to use.
This study tests whether a common medication called methylphenidate (often used for ADHD) can help children with sickle cell disease who have attention or memory problems. If the child qualifies, the study may offer a new way to improve focus and daily functioning.
This Phase 2 study tests a cognitive (thinking) training program to help teens with sickle cell disease prepare for the changes in their care as they grow older. It may help with skills like learning, attention, and planning for transition to adult care.
This study tests if taking zinc supplements can improve bone health in people with sickle cell disease. It's for those with certain types of sickle cell disease (SS or S-Beta zero thalassemia) who are not on chronic transfusions or zinc supplements.
This study looks at how blood vessel function in the fingers (using a simple test called arterial tonometry) relates to thinking and memory in people with sickle cell disease. It involves a non-invasive measurement and cognitive tasks.
This trial tests whether a computer-based “attention control” training program can improve attention and daily functioning in children with sickle cell disease. To join, you must meet certain criteria and also pass an initial attention screening test during the study.
Hear when a new Sickle Cell Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.